Arkolith/Insider Trading/PMVP/Form 4

Jalota Deepika

Chief Development OfficerPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Oct 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 13, 2024Grant(A)125K——125K
Aug 13, 2024Grant(A)91K——91K
Aug 13, 2024Disposed to issuer(D)125K——0
Aug 13, 2024Disposed to issuer(D)23K——0
Aug 13, 2024Disposed to issuer(D)68K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-024627) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML